Optimum Misoprostol Dose Prior to Office Hysteroscopy
- Conditions
- InfertilityAbnormal Uterine and Vaginal Bleeding, UnspecifiedRecurrent Abortion
- Interventions
- Registration Number
- NCT01612065
- Lead Sponsor
- Cairo University
- Brief Summary
Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.
- Detailed Description
The investigators will compare between 2 different doses of vaginal misoprostol, group (1) 200 ug, group (2) 400 ug, 3hours prior to office hysteroscopy , Infertile patient, patients with abnormal bleeding and patient with recurrent abortion Outcome measure: pain score, easiness of the procedure, procedure time, complications
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 132
- Female patient pre- or postmenopausal undergo office hysteroscopy.
- Age: from 20 to 60.
- BMI between 18 and 30.
- PID or
- Heavy uterine bleeding
- Cervical malignancy.
- Symptoms suggestive of endometriosis .
- Any cervical abnormality such as pinhole cervix that would obviate passage of a catheter through the cervix.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Misoprostol vaginally, 200 ug Misoprostol 200 ug misoprostol in the posterior vaginal fornix Misoprostol vaginally, 400ug Misoprostol Misoprostol in the posterior vaginal fornix
- Primary Outcome Measures
Name Time Method Pain score 1year Pain score by VAS
- Secondary Outcome Measures
Name Time Method Easiness 1year ease of entry of the office hysteroscopy into the cervix recorded on a 5-point Likert scale: very difficult= 1, difficult = 2, fair = 3, easy = 4, and very easy = 5;
Duration of the procedure 1year Duration of hysteroscopy in seconds
Trial Locations
- Locations (1)
Kasr alainy hospital, faculty of medicine , Cairo university
🇪🇬Cairo, Egypt